Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-09-28

MannKind (MNKD)

CEO Michael Castagna was paid $9,300,485 in fiscal year 2025, ↓ down 2.0% from fiscal year 2024, the 50th percentile of its disclosed peer group (SEC filing 0001193125-26-145613 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$9,300,485 ↓
Michael Castagna total, FY2025
50th
CEO pay percentile vs peers
46:1
CEO-to-median pay ratio
89.39%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

MNKD's next annual pay disclosure, estimated April 13, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Michael Castagna$789,436$0$7,689,480$0$675,757$0$145,812$9,300,485
Chief Executive Officer
Dominic Marasco447,59606,269,0150239,464024,3976,980,472
President, Endocrine Business Unit
David Thomson520,74802,133,4800378,6000122,4203,155,248
Executive Vice President, General Counsel and Secretary
Stuart Tross438,70902,133,4800234,7090138,7972,945,695
Executive Vice President, Human Resources
Christopher Prentiss470,08502,133,4800251,495031,7392,886,799
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Michael Castagna$9,300,485$9,490,628$7,068,114↓ −190,143
Dominic Marasco6,980,472———
David Thomson3,155,2483,059,8882,343,030↑ +95,360
Stuart Tross2,945,695———
Christopher Prentiss2,886,7993,352,852—↓ −466,053

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read MannKind's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper MNKD reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against MNKD
9 companies name MNKD as a compensation peer

The list of companies that name MNKD as a peer is temporarily unavailable — recheck shortly.

01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Christopher PrentissCFO$2,886,799
David ThomsonGeneral Counsel$3,155,248
Dominic MarascoEVP$6,980,472
Michael CastagnaCEO$9,300,485
Stuart TrossEVP$2,945,695
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Anthony HooperIndependent Director$319,852
Christine MundkurIndependent Director$306,543
James S. ShannonChair of the Board$349,043
Jennifer GrancioIndependent Director$311,543
Michael A. FriedmanIndependent Director$296,543
Ronald J. ConsiglioIndependent Director$321,543
Sabrina KayIndependent Director$307,352
Steven B. BinderDirector$291,543
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Christopher PrentissChief Financial Officer2026-04-22D12,267$3$33,612CommonForm 4 ↗
Michael CastagnaDirector2026-05-11D34,9574123,049CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-05-11D8,073428,417CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-05-11D12,387443,602CommonForm 4 ↗
Steven B. BinderDirector2026-05-11D5,560419,571CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-05-12D3,03339,979CommonForm 4 ↗
Steven B. BinderDirector2026-05-12D16,940355,733CommonForm 4 ↗
Dominic MarascoPres, Endocrine Business Unit2026-05-20A8,474324,998CommonForm 4 ↗
James S. ShannonDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Anthony HooperDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Jennifer GrancioDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Michael A. FriedmanDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Sabrina KayDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Christine MundkurDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-05-20A33,898399,999CommonForm 4 ↗
Anthony HooperDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A10,000329,500CommonForm 4 ↗
James S. ShannonDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
Steven B. BinderDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Steven B. BinderDirector2026-07-15A93,79000CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D5,372421,971CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15A70,55000CommonForm 4 ↗
Michael CastagnaDirector2026-07-15A350,26000CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15A93,79000CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D70,55000Derivative, Class A CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D22,047490,172CommonForm 4 ↗
Dominic MarascoPres, Endocrine Business Unit2026-07-15D3,623414,818CommonForm 4 ↗
Christopher PrentissChief Financial Officer2026-07-15D10,675443,661CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D16,378466,986CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D10,079441,223CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D350,26000Derivative, Class A CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D58,9044240,917CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D192,8194788,630CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D11,572447,329CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D8,253433,755CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D33,6524137,637CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15A93,79000CommonForm 4 ↗
Christopher PrentissChief Financial Officer2026-07-15D11,572447,329CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D4,073416,659CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D4,634418,953CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D15,688464,164CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D17,754472,614CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D12,662451,788CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D51,6324211,175CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D9,297438,025CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D63,9964261,744CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D47,4814194,197CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D12,331450,434CommonForm 4 ↗
Steven B. BinderDirector2026-07-17D52,4854213,089CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-17D24,109497,641CommonForm 4 ↗
Steven B. BinderDirector2026-08-07D39,0514158,547CommonForm 4 ↗
Steven B. BinderDirector2026-09-10D33,5584127,856CommonForm 4 ↗
Steven B. BinderDirector2026-09-25D39,0513128,478CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Christopher PrentissPSU2025-05-1372,500145,000—435,000$1,571,800
Christopher PrentissRSU2025-05-13——119,000—561,680
Stuart TrossPSU2025-05-1372,500145,000—435,0001,571,800
David ThomsonPSU2025-05-1372,500145,000—435,0001,571,800
Dominic MarascoRSU2025-02-12——252,000—1,411,200
Dominic MarascoRSU2025-05-14——59,500—271,915
David ThomsonRSU2025-05-13——119,000—561,680
Dominic MarascoRSU2025-06-23——1,000,000—3,800,000
Stuart TrossRSU2025-05-13——119,000—561,680
Michael CastagnaPSU2025-05-13261,500523,000—1,569,0005,669,320
Dominic MarascoPSU2025-05-1436,25072,500—217,500785,900
Michael CastagnaRSU2025-05-13——428,000—2,020,160
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Christopher Prentiss$561,680$1,571,800$073.7%
Stuart Tross561,6801,571,800073.7%
David Thomson561,6801,571,800073.7%
Dominic Marasco5,483,115785,900012.5%
Michael Castagna2,020,1605,669,320073.7%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Stuart TrossPSU145,000—$822,150
David ThomsonPSU113,000—640,710
Dominic MarascoRSU59,500—337,365
Michael CastagnaRSU348,750—1,977,413
Stuart TrossRSU46,000—260,820
David ThomsonRSU46,000—260,820
Christopher PrentissRSU103,600—587,412
Michael CastagnaPSU523,000—2,965,410
Michael CastagnaPSU422,000—2,392,740
Michael CastagnaPSU569,000—3,226,230
Michael CastagnaRSU428,000—2,426,760
Christopher PrentissPSU158,000—895,860
Michael CastagnaRSU63,500—360,045
Dominic MarascoPSU1,000,000—5,670,000
Dominic MarascoPSU72,500—411,075
Stuart TrossPSU158,000—895,860
David ThomsonPSU145,000—822,150
David ThomsonPSU158,000—895,860
Christopher PrentissPSU145,000—822,150
Christopher PrentissRSU119,000—674,730
Christopher PrentissRSU96,750—548,573
David ThomsonRSU22,500—127,575
David ThomsonRSU119,000—674,730
Stuart TrossRSU119,000—674,730
Stuart TrossPSU113,000—640,710
Stuart TrossRSU96,750—548,573
David ThomsonRSU96,750—548,573
Stuart TrossRSU22,500—127,575
Dominic MarascoRSU252,000—1,428,840
Michael CastagnaRSU172,500—978,075
05

Incentive-plan design — the Compensation Discussion & Analysis

This philosophy is to provide compensation and benefits programs designed to attract, engage, and retain a high caliber workforce that enables us to compete with companies in the pharmaceutical and biotechnology industries and to reward individual and corporate performance.

CEO STI target (% of salary)80%
CEO LTI target (% of salary)—
Independent consultantMercer LLC
Clawback policyTrue
Anti-hedgingtrue
Anti-pledgingfalse
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-20137,332,41816,295,1381,303,49789.39%Passed
20252025-05-14131,379,08211,526,7931,338,68391.93%Passed
20242024-05-15112,281,51711,612,5281,260,65489.71%Passed
20232023-05-25113,431,64711,361,3021,048,61690.9%Passed
20222022-05-1078,653,5649,044,5011,224,14888.45%Passed
20212021-05-2083,582,1347,850,0951,293,44190.14%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2089.39%a
20252025-05-1491.93%b
20242024-05-1589.71%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Approved under the standard stated in the filing — “Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as "Against" votes.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)46 : 1
CEO total compensation$9,300,485
Median employee compensation$203,592
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
James S. ShannonIndependent · Board Chair · Compensation$107,500$241,543$0$0$0$349,043
Ronald J. ConsiglioIndependent · Audit (Chair) · Nominating and Corporate Governance80,000241,543000321,543
Anthony HooperIndependent · Compensation (Chair) · Audit · Newly elected30,000289,852000319,852
Jennifer GrancioIndependent · Nominating and Corporate Governance (Chair) · Audit70,000241,543000311,543
Sabrina KayIndependent · Compensation · Audit · Newly elected17,500289,852000307,352
Christine MundkurIndependent · Audit · Nominating and Corporate Governance65,000241,543000306,543
Michael A. FriedmanIndependent · Nominating and Corporate Governance55,000241,543000296,543
Steven B. BinderNot independent50,000241,543000291,543
Michael E. CastagnaEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$241,543
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 25,000 / 10,000
Stock ownership guideline$150,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$475,000
Equity awards (grant-date value)$2,028,962
All other compensation$0
Total cost of the board$2,503,962

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies MannKind names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including MannKind.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1ADMA Biologics, Inc.2025Adam Grossman$925,000$4,049,994$4,049,998$1,156,250$10,237,326
2MannKind2025Michael Castagna789,4367,689,4800675,7579,300,485
3Travere Therapeutics, Inc.2025Eric Dube854,2503,314,5203,309,384964,1258,457,151

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
MannKind107%PSU 55 · RSU 45Yes — Total Stockholder Return (TSR) relative to Russell 3000 Pharmaceutical & Biotechnology IndexMercer LLC
ADMA Biologics, Inc.125%RSU 50 · Options 50not disclosedPay Governance LLC
Travere Therapeutics, Inc.150%not disclosedNoAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at MannKind in fiscal 2025?
As disclosed, Michael Castagna (Chief Executive Officer) was the highest-paid executive at MannKind in fiscal 2025, with total compensation of $9,300,485.
How does MannKind's chief executive pay compare to its disclosed peer group?
As disclosed, Michael Castagna's total compensation ranked at the 50th percentile of MannKind's disclosed peer group.
What is MannKind's CEO-to-median employee pay ratio?
As disclosed, MannKind's CEO-to-median employee pay ratio was 46:1.
How did shareholders vote on MannKind's executive compensation?
As disclosed, 89.39% of shareholders supported MannKind's executive compensation in the latest say-on-pay vote.
How much does MannKind spend in total on board compensation for fiscal 2025?
As disclosed, MannKind reported total board compensation of $2,503,962 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Michael CastagnaDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 9,300,485. Filing ↗machine: t24 · r5 · c27 · span 606612–606621
2Section 01, Dominic MarascoDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 6,980,472. Filing ↗machine: t24 · r12 · c27 · span 673006–673015
3Section 01, David ThomsonDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 3,155,248. Filing ↗machine: t24 · r15 · c27 · span 698680–698689
4Section 01, Stuart TrossDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 2,945,695. Filing ↗machine: t24 · r19 · c27 · span 736983–736992
5Section 01, Christopher PrentissDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 2,886,799. Filing ↗machine: t24 · r9 · c27 · span 644922–644931
6Section 03, Christopher Prentiss PSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 840039–840048
7Section 03, Christopher Prentiss RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 852114–852121
8Section 03, Stuart Tross PSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 972830–972839
9Section 03, David Thomson PSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 936618–936627
10Section 03, Dominic Marasco RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 876255–876264
11Section 03, Dominic Marasco RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 900400–900407
12Section 03, David Thomson RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 948693–948700
13Section 03, Dominic Marasco RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 912475–912484
14Section 03, Stuart Tross RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 984905–984912
15Section 03, Michael Castagna PSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 803812–803821
16Section 03, Dominic Marasco PSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 888328–888335
17Section 03, Michael Castagna RSUDEF 14A1900-01-010001193125-26-145613Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 815887–815896
18Section 07, pay ratioDEF 14A2026-04-070001193125-26-145613Section “CEO Pay Ratio”. As printed: 46 : 1. Filing ↗machine: span 1491900–1491902
19Section 08, James S. ShannonDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 349,043. Filing ↗machine: span 333252–333461
20Section 08, Ronald J. ConsiglioDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 321,543. Filing ↗machine: t14 · r3 · c8 · span 312998–313207
21Section 08, Anthony HooperDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 319,852. Filing ↗machine: t14 · r6 · c8 · span 323641–323850
22Section 08, Jennifer GrancioDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 311,543. Filing ↗machine: t14 · r5 · c8 · span 320093–320302
23Section 08, Sabrina KayDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 307,352. Filing ↗machine: t14 · r7 · c8 · span 327186–327395
24Section 08, Christine MundkurDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 306,543. Filing ↗machine: t14 · r8 · c8 · span 330733–330942
25Section 08, Michael A. FriedmanDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 296,543. Filing ↗machine: t14 · r4 · c8 · span 316547–316756
26Section 08, Steven B. BinderDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 291,543. Filing ↗machine: t14 · r2 · c8 · span 309449–309658
27Section 08, Michael E. CastagnaDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 0. Filing ↗
28Section 02, Christopher Prentiss 2026-04-22Form 42026-04-240001193125-26-178298Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Michael Castagna 2026-05-11Form 42026-05-130001193125-26-222309Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Stuart Tross 2026-05-11Form 42026-05-130001193125-26-222312Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, David Thomson 2026-05-11Form 42026-05-130001193125-26-222310Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Steven B. Binder 2026-05-11Form 42026-05-130001193125-26-222311Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, David Thomson 2026-05-12Form 42026-05-130001193125-26-222310Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Steven B. Binder 2026-05-12Form 42026-05-130001193125-26-222311Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Dominic Marasco 2026-05-20Form 42026-05-220001193125-26-237428Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, James S. Shannon 2026-05-20Form 42026-05-220001193125-26-237430Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Anthony Hooper 2026-05-20Form 42026-05-220001193125-26-237431Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Jennifer Grancio 2026-05-20Form 42026-05-220001193125-26-237432Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Michael A. Friedman 2026-05-20Form 42026-05-220001193125-26-237456Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Sabrina Kay 2026-05-20Form 42026-05-220001193125-26-237424Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Christine Mundkur 2026-05-20Form 42026-05-220001193125-26-237426Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Stuart Tross 2026-05-20Form 42026-05-220001193125-26-237429Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Anthony Hooper 2026-05-20Form 42026-05-220001193125-26-237431Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, James S. Shannon 2026-05-20Form 42026-05-220001193125-26-237430Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Steven B. Binder 2026-05-20Form 42026-05-220001193125-26-237438Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Dominic Marasco 2026-07-15Form 42026-07-170001193125-26-308137Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Christopher Prentiss 2026-07-15Form 42026-07-170001193125-26-308139Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Christopher Prentiss 2026-07-15Form 42026-07-170001193125-26-308139Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Steven B. Binder 2026-07-17Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, David Thomson 2026-07-17Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Steven B. Binder 2026-08-07Form 42026-08-100001193125-26-343016Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Steven B. Binder 2026-09-10Form 42026-09-140001193125-26-391003Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Steven B. Binder 2026-09-25Form 42026-09-280001193125-26-405736Insider equity transaction reported since the proxy statement. Filing ↗
86Section 06, 2026 voteForm 8-K2026-05-220001193125-26-237183Item 5.07 · say-on-pay result. As reported: 89.39% (votes for as printed: 137,332,418). Filing ↗
87Section 06, 2025 voteForm 8-K2025-05-190000950170-25-074523Item 5.07 · say-on-pay result. As reported: 91.93% (votes for as printed: 131,379,082). Filing ↗
88Section 06, 2024 voteForm 8-K2024-05-160000950170-24-061164Item 5.07 · say-on-pay result. As reported: 89.71% (votes for as printed: 112,281,517). Filing ↗
89Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
90Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
91Section 09b board cost (computed)Computed——Cash 475,000 + equity 2,028,962 + all other 0 = 2,503,962, summed across the director compensation table rows.machine: formula: Σ = 2,503,962
92ADMA Biologics, Inc., Section 10b CEO totalDEF 14A2026-04-150001140361-26-014799CEO total compensation as printed in ADMA Biologics, Inc.'s own proxy. As printed: 10,237,326. Filing ↗machine: r2 · c25 · span 619658–619669
93MannKind (subject), Section 10b CEO totalDEF 14A2026-04-070001193125-26-145613CEO total compensation as printed in MannKind's own proxy. As printed: 9,300,485. Filing ↗machine: t24 · r5 · c27 · span 606612–606621
94Travere Therapeutics, Inc., Section 10b CEO totalDEF 14A2026-04-060001438533-26-000027CEO total compensation as printed in Travere Therapeutics, Inc.'s own proxy. As printed: 8,457,151. Filing ↗machine: span 558514–558523
95Section 10a, Travere Therapeutics, Inc. reciprocityDEF 14A—0001438533-26-000027Travere Therapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include MannKind. Filing ↗
96Section 10a, ADMA Biologics, Inc. reciprocityDEF 14A—0001140361-26-014799ADMA Biologics, Inc. names MannKind in its own disclosed peer group (read from its most recent proxy). Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.